Product Information
GLPG-0187 is an anti-cancer drug that inhibits the proliferation of cancer cells by inducing apoptosis. GLPG-0187, an integrin receptor antagonist, can be used for the treatment of prostate cancer and melanoma. It has been shown to inhibit the growth of malignant melanoma cells in vivo models and it has also shown to decrease the expression of mesenchymal markers on prostate cancer cells. GLPG-0187 inhibits tumor growth through a number of mechanisms, including inhibition of cell proliferation and induction of apoptosis. It also blocks some signaling pathways associated with tumorigenesis and angiogenesis.
Chemical properties
Technical inquiry about: 3D-VCC34697 GLPG-0187
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
